Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Non Operating Income (2020 - 2025)

Immucell (ICCC) has disclosed Non Operating Income for 9 consecutive years, with -$155367.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 23.84% year-over-year to -$155367.0, compared with a TTM value of $9314.0 through Sep 2025, up 101.7%, and an annual FY2024 reading of -$506414.0, down 2213.13% over the prior year.
  • Non Operating Income was -$155367.0 for Q3 2025 at Immucell, down from -$65778.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $331263.0 in Q1 2025 and bottomed at -$155367.0 in Q3 2025.
  • Average Non Operating Income over 5 years is -$49480.3, with a median of -$70156.0 recorded in 2021.
  • Peak annual rise in Non Operating Income hit 809.67% in 2023, while the deepest fall reached 314.04% in 2023.
  • Year by year, Non Operating Income stood at -$70156.0 in 2021, then surged by 53.53% to -$32602.0 in 2022, then plummeted by 314.04% to -$134985.0 in 2023, then grew by 25.32% to -$100804.0 in 2024, then crashed by 54.13% to -$155367.0 in 2025.
  • Business Quant data shows Non Operating Income for ICCC at -$155367.0 in Q3 2025, -$65778.0 in Q2 2025, and $331263.0 in Q1 2025.